Irodalom
1. Abdel-Wahab M. El-Shennawy F. Agha S. Ragab E. Fathi
O. Sultan A. Elghawalby N. Ezzat F.: Evaluation of cell
mediated immunity in advanced pancreatic carcinoma before
and after treatment with interleukin-2 (IL-2).
Hepato-Gastroenterology. 46 Suppl 1:1293-6, 1999 May.
2. Barton MB. Kneebone AB.: Adjuvant therapy for rectal
cancer can no longer be ignored. Australian & New Zealand
Journal of Surgery. 69(9):619-21, 1999 Sep.
3. Berlin J. Merrick HW. Smith TJ.: Lerner H Phase II
evaluation of treatment of complete resection of hepatic
metastases from colorectal cancer and adjuvant hepatic
arterial infusion of floxuridine: an Eastern Cooperative
Oncology Group Study (PB083). American Journal of
Clinical Oncology. 22(3):291-3, 1999 Jun.
4. Bleiberg H.: CPT-11 in gastrointestinal cancer. [Review][85
refs] European Journal of Cancer. 35(3):371-9, 1999 Mar.
5. Bozzetti F. Baratti D. Andreola S. Zucali R. Schiavo M.
Spinelli P. Gronchi A. Bertario L. Mariani L. Gennari L.:
Preoperative radiation therapy for patients with T2-T3
carcinoma of the middle-to-lower rectum. Cancer.
86(3):398-404, 1999 Aug 1.
6. Cassidy J.: Potential of Xeloda in colorectal cancer and other
solid tumors. [Review] [26 refs] Oncology. 57 Suppl
1:27-32, 1999 Jul.
7. Cerottini JP. Caplin S. Pampallona S. Givel JC.:
Prognostic factors in colorectal cancer. Oncology Reports.
6(2):409-14, 1999 Mar-Apr.
8. Cunningham D.: Setting a new standard–irinotecan
(Campto) in the second-line therapy of colorectal cancer:
final results of two phase III studies and implications for
clinical practice. [Review] [29 refs] Seminars in Oncology.
26(1 Suppl 5):1-5, 1999 Feb.
9. Eriguchi N. Aoyagi S. Fukuda S. Hara M. Imamura I.
Hashino K. Hashimoto M. Tanaka E. Tanaka M.: A
long-term survival patient with advanced gallbladder cancer
massively metastasizing to the liver. [Review] [17 refs]
Kurume Medical Journal. 46(1):83-6, 1999.
10. Faivre J. Bonithon-Kopp C.: Chemoprevention of colorectal
cancer. [Review] [25 refs] Recent Results in Cancer
Research. 151:122-33, 1999
11. Fata F. Ron IG. Kemeny N. O’Reilly E. Klimstra D. Kelsen
DP.: 5-fluorouracil-induced small bowel toxicity in patients
with colorectal carcinoma. Cancer. 86(7):1129-34, 1999 Oct
1.
12. Ferreri AJ. Cordio S. Ponzoni M. Villa E.: Non-surgical
treatment with primary chemotherapy, with or without
radiation therapy, of stage I-II high-grade gastric lymphoma.
Leukemia & Lymphoma. 33(5-6):531-41, 1999 May.
13. Fountzilas G. Zisiadis A. et al.: Postoperative radiation and
concomitant bolus fluorouracil with or without additional
chemotherapy with fluorouracil and high-dose leucovorin in
patients with high-risk rectal cancer: a randomized phase III
study conducted by the Hellenic Cooperative Oncology
Group. Annals of Oncology. 10(6):671-6, 1999 Jun.
14. Grodstein F. Newcomb PA. Stampfer MJ.: Postmenopausal
hormone therapy and the risk of colorectal cancer: a review
and meta-analysis. American Journal of Medicine.
106(5):574-82, 1999 May.
15. Groen KA.: Primary and metastatic liver cancer. [Review]
[55 refs] O’Connor KG.: Gastric cancer. [Review] [41 refs]
Seminars in Oncology Nursing. 15(1):26-35, 1999 Feb.
16. Gunderson LL. Haddock MG. Burch P. Nagorney D. Foo
ML. Todoroki T.: Future role of radiotherapy as a
component of treatment in biliopancreatic cancers. [Review]
[30 refs] Annals of Oncology. 10 Suppl 4:291-5, 1999.
17. Gunderson LL.: Indications for and results of combined
modality treatment of colorectal cancer [see comments].
[Review] [52 refs] Acta Oncologica. 38(1):7-21, 1999.
18. Hanazaki K. Mochizuki Y. Machida T. Yokoyama S.
Sodeyama H. Sode Y. Wakabayashi M. Kawamura N.
Miyazaki T.: Post-operative chemotherapy in non-curative
gastrectomy for advanced gastric cancer.
Hepato-Gastroenterology. 46(26):1238-43, 1999 Mar-Apr.
19. Janjan NA. Abbruzzese J. Pazdur R. Khoo VS. Cleary K.
Dubrow R. Ajani J. Rich TA. Goswitz MS. Evetts PA. Allen
PK. Lynch PM. Skibber JM.: Prognostic implications of
response to preoperative infusional chemoradiation in locally
advanced rectal cancer. Radiotherapy & Oncology.
51(2):153-60, 1999 May.
20. Kainuma O. Asano T. Aoyama H. Takayama W. Nakagohri
T. Kenmochi T. Hasegawa M. Tokoro Y. Sasagawa S.
Ochiai T.: Combined therapy with radiofrequency thermal
ablation and intra-arterial infusion chemotherapy for hepatic
metastases from colorectal cancer. Hepato-Gastroenterology.
46(26):1071-7, 1999 Mar-Apr.
21. Kolh P. Honore P. Gielen JL. Degauque C. Azzam C.
Legrand M. Jacquet N.: Analysis of factors influencing
long-term survival after surgical resection for oesophageal
squamous cell carcinoma. Acta Chirurgica Belgica.
99(3):113-8, 1999 May-Jun.
22. Konno H. Tanaka T. Baba M. Kanai T. Nakamura S.:
Antiangiogenic therapy for liver metastasis of
gastrointestinal malignancies. ( Review ) (30 refs) Journal of
Hepato-Biliary-Pancreatic Surgery. 6(1):1-6, 1999.
23. Lehnert T.: Multimodal therapy for squamous carcinoma of
the oesophagus. [Review] [69 refs] British Journal of
Surgery. 86(6):727-39, 1999 Jun.
24. Leichman CG. Jacobson JR. Modiano M. Daniels JR.
Zalupski MM. Doroshow JH. Fletcher WS. Macdonald JS.:
Hepatic chemoembolization combined with systemic
infusion of 5-fluorouracil and bolus leucovorin for patients
with metastatic colorectal carcinoma: A Southwest Oncology
Group pilot trial. Cancer. 86(5):775-81, 1999 Sep 1.
25. Litvak DA. Papaconstantinou HT. Hwang KO. Kim M.
Evers BM. Townsend CM Jr.: Inhibition of gastric cancer by
camptothecin involves apoptosis and multiple cellular
pathways. Surgery. 126(2):223-30, 1999 Aug.
Gastro Update’99 – Nyelőcső
26. Madura JA. Jarman BT. Doherty MG. Yum MN. Howard
TJ. Adenosquamous carcinoma of the pancreas. [Review]
[36 refs] Archives of Surgery. 134(6):599-603, 1999 Jun.
27. Makrauer FL. Oates E. Becker J. Abrams R. O’Connor T.
McCallum R. Shumaker J.: Does local irradiation affect
gastric emptying in humans?. American Journal of the
Medical Sciences. 317(1):33-7, 1999 Jan.
28. Mannaerts GH. Martijn H. Crommelin MA. Stultiens GN.
Dries W. van Driel OJ. Rutten HJ.: Intraoperative electron
beam radiation therapy for locally recurrent rectal carcinoma.
International Journal of Radiation Oncology, Biology,
Physics. 45(2):297-308, 1999 Sep 1.
29. Martenson JA. Shanahan TG. O’Connell MJ. Cobau CD.
Schroeder G. Burch PA. Levitt R. Rowland KM Jr.: Phase
I study of 5-fluorouracil administered by protracted venous
infusion, leucovorin, and pelvic radiation therapy. Cancer.
86(4):710-4, 1999 Aug 15.
30. Midgley R. Kerr D.: Colorectal cancer. Lancet.
353(9150):391-9, 1999 Jan 30.
Newcomb PA. Taylor JO. Trentham-Dietz A.: Interactions of
familial and hormonal risk factors for large bowel cancer in
women. International Journal of Epidemiology. 28(4):603-8,
1999 Aug.
31. Minsky BD.: Adjuvant postoperative combined-modality
therapy for rectal cancer. [Review] [33 refs] Oncology.
13(7 Suppl 3):132-5, 1999 Jul.
32. Nakajima T. Nashimoto A. Kitamura M. Kito T. Iwanaga T.
Okabayashi K. Goto M.: Adjuvant mitomycin and
fluorouracil followed by oral uracil plus tegafur in
serosa-negative gastric cancer: a randomised trial. Gastric
Cancer Surgical Study Group. Lancet. 354(9175):273-7,
1999 Jul 24.
33. Nijsen JF. Zonnenberg BA. Woittiez JR. Rook DW.
Swildens-van Woudenberg IA. van Rijk PP. van het Schip
AD.: Holmium-166 poly lactic acid microspheres applicable
for intra-arterial radionuclide therapy of hepatic
malignancies: effects of preparation and neutron activation
techniques. European Journal of Nuclear Medicine.
26(7):699-704, 1999 Jul.
34. Peeters M. Haller DG.: Therapy for early-stage colorectal
cancer. [Review] [45 refs] Oncology. 13(3):307-15;
discussion 315-7, 320-1, 1999 Mar.
35. Roukos DH. Current advances and changes in treatment
strategy may improve survival and quality of life in patients
with potentially curable gastric cancer. [Review] [86 refs]
Annals of Surgical Oncology. 6(1):46-56, 1999
Jan-Feb.Seminars in Oncology. 26(1 Suppl 5):1-5, 1999 Feb.
36. Royce ME. Pazdur R.: Novel chemotherapeutic agents for
gastrointestinal cancers. [Review] [63 refs] Current Opinion
in Oncology. 11(4):299-304, 1999 Jul.
37. Safran H. Akerman P. Cioffi W. Gaissert H. Joseph P.
King T. Hesketh PJ. Wanebo H.: Paclitaxel and concurrent
radiation therapy for locally advanced adenocarcinomas of
the pancreas, stomach, and gastroesophageal junction.
Seminars in Radiation Oncology. 9(2 Suppl 1):53-7, 1999
Apr.
38. Sporn JR.: Practical recommendations for the management
of adenocarcinoma of the pancreas. [Review] [48 refs]
Drugs. 57(1):69-79, 1999 Jan.
39. Stein U. Rau B. Wust P. Walther W. Schlag PM.:
Hyperthermia for treatment of rectal cancer: evaluation for
induction of multidrug resistance gene (mdr1) expression.
International Journal of Cancer. 80(1):5-12, 1999 Jan 5.
40. Stucky-Marshall L.: New agents in gastrointestinal
malignancies: Part 1: Irinotecan in clinical practice.
[Review] [22 refs] Cancer Nursing. 22(3):212-9, 1999 Jun.
41. Todoroki T. Kawamoto T. Otsuka M. Koike N. Yoshida
S. Takada Y. Adachi S. Kashiwagi H. Fukao K. Ohara
K.: Benefits of combining radiotherapy with aggressive
resection for stage IV gallbladder cancer.
Hepato-Gastroenterology. 46(27):1585-91, 1999 May-Jun.
42. Van Cutsem E. Peeters M.: Developments in
fluoropyrimidine therapy for gastrointestinal cancer.
[Review] [44 refs] Current Opinion in Oncology.
11(4):312-7, 1999 Jul.
43. Varma MG. Rogers SJ. Schrock TR. Welton ML.: Local
excision of rectal carcinoma. Archives of Surgery.
134(8):863-7; discussion 867-8, 1999 Aug.
44. Wagman R. Minsky BD. Cohen AM. Saltz L. Paty PB.
Guillem JG. : Conservative management of rectal cancer
with local excision and postoperative adjuvant therapy.
International Journal of Radiation Oncology, Biology,
Physics. 44(4):841-6, 1999 Jul 1.
45. Willett CG. Badizadegan K. Ancukiewicz M. Shellito PC.:
Prognostic factors in stage T3N0 rectal cancer: do all
patients require postoperative pelvic irradiation and
chemotherapy?. Diseases of the Colon & Rectum.
42(2):167-73, 1999 Feb.
46. Wiseman LR. Adkins JC. Plosker GL. Goa KL.: Oxaliplatin:
a review of its use in the management of metastatic
colorectal cancer. [Review] [89 refs] Drugs & Aging.
14(6):459-75, 1999 Jun.
47. Worthington TR. Williamson RC.: The continuing challenge
of exocrine pancreatic cancer. Comprehensive Therapy.
25(6-7):360-5, 1999 Jun-Jul.
48. Yoon SS. Tanabe KK.: Surgical treatment and other
regional treatments for colorectal cancer liver metastases.
[Review] [102 refs]Journal of Hazardous Materials.
4(3):197-208, 1999
